OBJECTIVE:
This product intends to provide financial protection to women against the diagnosis of cancer at a very affordable cost.
The following cancers are covered under this product:
100% of Sum Assured is payable on diagnosis of the cancer verified by provision of the histopathological report.
Policy will be issued for a period of one year which may be renewed at the end of the policy year. Premium rates subject to review by State Life each year
All Pakistani females aged 18-64 will be eligible for this product.
In the first policy year, coverage would commence after 90 days from the day a complete application is received by State Life along with the Full Premium. In case the policy is renewed in continuation of the coverage with State Life, the waiting period will be waived from the next year.
An individual female can choose from any of the following plans according to her needs:
Plan Name | Benefit Amount (Rs.) |
SACP-1 | 200,000/- |
SACP-2 | 300,000/- |
SACP-3 | 500,000/- |
SACP-4 | 1,000,000/- |
SACP-5 | 1,500,000/- |
The diagnosis of a malignant tumor characterized by the uncontrolled growth and spread of malignant cells with invasion of normal tissue. The diagnosis of cancer must be verified by provision of the histopathological report. Cancer includes: leukaemia, malignant lymphoma including cutaneous lymphoma, Hodgkin's disease, malignant bone marrow disorders, and sarcoma. The following are excluded:
"Carcinoma in situ" or "cancer in situ" or dysplasia or pre-malignant conditions or non-invasive cancers.
These conditions are risk markers for invasive cancer but are not life-threatening or causes of significant morbidity except diffuse ('flat') non-papillary urinary bladder carcinoma in situ (Tis). Binet stage A Chronic Lymphatic Leukemia.